Literature DB >> 9596007

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

J W Brans1, R Lindeboom, M Aramideh, J D Speelman.   

Abstract

We investigated the long-term effect of botulinum toxin type A (BTA) on impairment as well as functional health in terms of disability, handicap, and quality of life in 64 patients with cervical dystonia. These patients, who first participated in a double-blind trial, were followed for another 12 months. Fifty-four patients continued treatment after 12 months of follow-up and showed improvement on all scales. Furthermore, this effectiveness appeared to increase during follow-up, which suggests a cumulative clinical effect of BTA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596007     DOI: 10.1212/wnl.50.5.1461

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Cervical Dystonia (Torticollis).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

3.  Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.

Authors:  R Hilker; M Schischniaschvili; M Ghaemi; A Jacobs; J Rudolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 4.  Updated perspectives on neurogenic thoracic outlet syndrome.

Authors:  Paul J Christo; Kai McGreevy
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 5.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.

Authors:  Carlo Colosimo; Dorina Tiple; Alfredo Berardelli
Journal:  Neurotox Res       Date:  2012-02-23       Impact factor: 3.911

7.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

Review 8.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

10.  Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

Authors:  Margherita Fabbri; Maria Superbo; Giovanni Defazio; Cesa Lorella Maria Scaglione; Elena Antelmi; Giacomo Basini; Stefania Nassetti; Fabio Pizza; Rosaria Plasmati; Rocco Liguori
Journal:  Neurol Sci       Date:  2014-01-30       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.